Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Clinical Characteristics and Survival Outcomes of Patients with Primary and Secondary Plasma Cell Leukemia According to the 2021 Definition: A Single Center Retrospective Study

Khalid Shalaby, Farhan Azad, Sarah Parker, Katy Wang, Kristopher Attwood, Jens Hillengass

Blood (2024) 144 (Supplement 1): 6960.

https://doi.org/10.1182/blood-2024-198790

Published: 2024

Journal Articles

Clinical Outcomes of Lymphoplasmacytic Lymphoma / Waldenstrom Macroglobulinemia (LPL/WM) in the Targeted Therapy Era: A US Multicenter Retrospective Analysis

Blood (2024) 144 (Supplement 1): 4392.

https://doi.org/10.1182/blood-2024-199278

Published: 2024

Journal Articles

Optimal Therapeutic Strategies in Relapsed/Refractory AML with Prior Exposure to Venetoclax Based Therapy

Sawyer Bawek, Prutha Patel, Katy Wang, Kristopher Attwood, Tara Cronin, Melissa Fos, Steven Green, Pamela Jeannette Sung, James E Thompson, Elizabeth A. Griffiths, Eunice S Wang, Amanda C. Przespolewski

Blood (2023) 142 (Supplement 1): 4271.

https://doi.org/10.1182/blood-2023-190790

Published: 2023

Journal Articles

Disease Control Affects Outcomes of Patients with Relapsed Diffuse Large B Cell Lymphoma Treated with CD19 Directed CAR T-Cell Therapy

Dorothy C Pan, Showkat Hamid, Megan Herr, Kristopher Attwood, Philip L. McCarthy, Maureen Ross, Grant Schofield, Matthew J Cortese, Dominick Lamonica, Jerry Thwin Wong, Kai Fu, Peter Maslak, Marco Davila, Renier Brentjens, Francisco J. Hernandez-Ilizaliturri

Blood (2023) 142 (Supplement 1): 7376.

https://doi.org/10.1182/blood-2023-187631

Published: 2023

Journal Articles

Treatment Selection and Clinical Outcomes in Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia (LPL/WM) - a Single Center Analysis

Muhammad Junaid Tariq, Andrea Carolina Anampa-Guzmán, Malak Alharbi, Khalid Shalaby, Riya Patel, Showkat Hamid, Anthony George, Kristopher Attwood, Francisco J. Hernandez-Ilizaliturri, Matthew J Cortese

Blood (2023) 142 (Supplement 1): 4421.

https://doi.org/10.1182/blood-2023-181306

Published: 2023

Journal Articles

Effects of Dose Reductions of Lenalidomide Given As Maintenance Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma

Ian Lund, Farhan Azad, Kristopher Attwood, Anthony George, Jens Hillengass

Blood (2023) 142 (Supplement 1): 3365.

https://doi.org/10.1182/blood-2023-181708

Published: 2023

Journal Articles

Real-World Clinical Outcomes of Multiple Myeloma Patients with High-Risk Cytogenetics Treated with Dararvd, Single Center Experience

Sheeba Ba Aqeel, Alankrita Taneja, Adrienne Groman, Sarah Parker, Karan Jatwani, Arya Mariam Roy, Kristopher Attwood, Philip L. McCarthy, Jens Hillengass

Blood (2022) 140 (Supplement 1): 13216–13217.

https://doi.org/10.1182/blood-2022-165549

Published: 2022

Journal Articles

Immune Markers of Multiple Myeloma Patients Demonstrate Significant Change after Participation in Six-Month Physical Activity Intervention

Janine M. Joseph, Michaela Hillengass, Hillary Jacobson, Joseph D. Tario, Jr., Kristopher Attwood, Adrienne Groman, Rikki Cannioto, Bryan Wittmeyer, Kirsten Moysich, Scott I. Abrams, Jens Hillengass

Blood (2022) 140 (Supplement 1): 12630–12632.

https://doi.org/10.1182/blood-2022-167655

Published: 2022

Journal Articles

Galectin-3 Signaling in Donor T Cells Regulates Acute Graft Versus Host Disease (aGvHD) after Allogenic Transplantation

Hemn Mohammadpour, Takemasa Tsuji, Cameron R. MacDonald, Joseph L. Sarow, Jingxin Qiu, Junko Matsuzaki, Kristopher Attwood, Bruce R. Blazar, Kunle Odunsi, Elizabeth A. Repasky, Philip L. McCarthy

Blood (2021) 138 (Supplement 1): 2765.

https://doi.org/10.1182/blood-2021-150777

Published: 2021

Journal Articles

Evaluating the Role of Baseline Geriatric Assessment in Predicting Quality of Life in Older Adults with Non-Hodgkin Lymphoma on Oral Targeted Therapies

Othman Salim Akhtar, Chong Wang, Kristopher Attwood, Desi Carozza, Elizabeth R. Gage-Bouchard, Tunazzina Kaijar, Paola Ghione, Francisco J. Hernandez-Ilizaliturri, Tanya M. Wildes, Pallawi Torka

Blood (2021) 138 (Supplement 1): 4094.

https://doi.org/10.1182/blood-2021-149934

Published: 2021

Journal Articles

Phase 1b Trial of Talazoparib and Gemtuzumab Ozogamicin in Adult Patients with CD33+ Relapsed or Refractory Acute Myeloid Leukemia

Mahesh Swaminathan, Amanda Przespolewski, Elizabeth A. Griffiths, James E. Thompson, Amro Elshoury, Wendy Walinski, Meriem Said, Stephanie Halliwell, Claire Puff, Kristopher Attwood, Eunice S. Wang

Blood (2021) 138 (Supplement 1): 4435.

https://doi.org/10.1182/blood-2021-151636

Published: 2021

Journal Articles

Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies

Blood (2021) 138 (9): 811–814.

https://doi.org/10.1182/blood.2021012443

Published: 2021

Includes: Supplemental data

Journal Articles

Phase 1/1b Trial of Talazoparib and Gemtuzumab Ozogamicin in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia

Amanda Przespolewski, DO, Elizabeth A. Griffiths, MD, James E. Thompson, MD, Amro Elshoury, MBBChir, Ashkan Emadi, MD, PhD, Vu H. Duong, MD, Sandrine Niyongere, MD, Wendy Walinski, Meriem Said, Stephanie Halliwell, Kemji Eke, Kristopher Attwood, PhD, Maria R. Baer, MD, Eunice S. Wang, MD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-141736

Published: 2020

Journal Articles

Utility of Bone Marrow Biopsy in the Staging of T-Cell Lymphoma in the PET-CT Era

Suchitra Sundaram, MD, Matthew Gravina, MD, Kristopher Attwood, PhD, Francisco J. Hernandez-Ilizaliturri, MD, Pallawi Torka, MD

Blood (2019) 134 (Supplement_1): 4039.

https://doi.org/10.1182/blood-2019-130382

Published: 2019

Journal Articles

Early Complete Remission By Functional Imaging and Intensified Frontline Therapy Are Associated with an Improved Clinical Outcome in Patients with Newly Diagnosed T-Cell Lymphoma- a Single Center Experience

Suchitra Sundaram, MD, Matthew Gravina, MD, Pallawi Torka, MD, Kristopher Attwood, PhD, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2019) 134 (Supplement_1): 4058.

https://doi.org/10.1182/blood-2019-132244

Published: 2019

Journal Articles

Decitabine Is More Cost Effective Than Standard Conventional Induction Therapy In Elderly Acute Myeloid Leukemia Patients

Nicolas Batty, MD, Samuel Wiles, Mathew Kabalan, Rohit Sharma, MD, Joseph Shatzel, MD, Jonathan Pang, David Yi, Iris Alatovic, Sana Saif, MD, Deepika Narasimha, Joseph LaPenna, Anthony Troitino, MD, Kristopher Attwood, MS, Yong Yin, PhD, Meir Wetzler, MD

Blood (2013) 122 (21): 2699.

https://doi.org/10.1182/blood.V122.21.2699.2699

Published: 2013

NARROW

Clinical Characteristics and Survival Outcomes of Patients with Primary and Secondary Plasma Cell Leukemia According to the 2021 Definition: A Single Center Retrospective Study

Clinical Outcomes of Lymphoplasmacytic Lymphoma / Waldenstrom Macroglobulinemia (LPL/WM) in the Targeted Therapy Era: A US Multicenter Retrospective Analysis

Optimal Therapeutic Strategies in Relapsed/Refractory AML with Prior Exposure to Venetoclax Based Therapy

Disease Control Affects Outcomes of Patients with Relapsed Diffuse Large B Cell Lymphoma Treated with CD19 Directed CAR T-Cell Therapy

Treatment Selection and Clinical Outcomes in Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia (LPL/WM) - a Single Center Analysis

Effects of Dose Reductions of Lenalidomide Given As Maintenance Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma

Real-World Clinical Outcomes of Multiple Myeloma Patients with High-Risk Cytogenetics Treated with Dararvd, Single Center Experience

Immune Markers of Multiple Myeloma Patients Demonstrate Significant Change after Participation in Six-Month Physical Activity Intervention

Galectin-3 Signaling in Donor T Cells Regulates Acute Graft Versus Host Disease (aGvHD) after Allogenic Transplantation

Evaluating the Role of Baseline Geriatric Assessment in Predicting Quality of Life in Older Adults with Non-Hodgkin Lymphoma on Oral Targeted Therapies

Phase 1b Trial of Talazoparib and Gemtuzumab Ozogamicin in Adult Patients with CD33+ Relapsed or Refractory Acute Myeloid Leukemia

Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies

Phase 1/1b Trial of Talazoparib and Gemtuzumab Ozogamicin in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia

Utility of Bone Marrow Biopsy in the Staging of T-Cell Lymphoma in the PET-CT Era

Early Complete Remission By Functional Imaging and Intensified Frontline Therapy Are Associated with an Improved Clinical Outcome in Patients with Newly Diagnosed T-Cell Lymphoma- a Single Center Experience

Decitabine Is More Cost Effective Than Standard Conventional Induction Therapy In Elderly Acute Myeloid Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only